Wei Yibing, Song Dingka, Wang Ran, Li Tingting, Wang Hui, Li Xiaoguang
State Key Laboratory of Oncogenes and Related Genes, Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
College of Medical Technology, Shanghai University of Medicine and Health Sciences, Shanghai, China.
Front Oncol. 2023 Mar 8;13:1038710. doi: 10.3389/fonc.2023.1038710. eCollection 2023.
Immunotherapies are recently emerged as a new strategy in treating various kinds of cancers which are insensitive to standard therapies, while the clinical application of immunotherapy is largely compromised by the low efficiency and serious side effects. Gut microbiota has been shown critical for the development of different cancer types, and the potential of gut microbiota manipulation through direct implantation or antibiotic-based depletion in regulating the overall efficacy of cancer immunotherapies has also been evaluated. However, the role of dietary supplementations, especially fungal products, in gut microbiota regulation and the enhancement of cancer immunotherapy remains elusive. In the present review, we comprehensively illustrated the limitations of current cancer immunotherapies, the biological functions as well as underlying mechanisms of gut microbiota manipulation in regulating cancer immunotherapies, and the benefits of dietary fungal supplementation in promoting cancer immunotherapies through gut microbiota modulation.
免疫疗法最近已成为治疗各种对标准疗法不敏感癌症的一种新策略,然而免疫疗法的临床应用在很大程度上受到低效率和严重副作用的影响。肠道微生物群已被证明对不同类型癌症的发展至关重要,通过直接植入或基于抗生素的消耗来操纵肠道微生物群在调节癌症免疫疗法整体疗效方面的潜力也已得到评估。然而,膳食补充剂,尤其是真菌产品,在调节肠道微生物群和增强癌症免疫疗法中的作用仍然难以捉摸。在本综述中,我们全面阐述了当前癌症免疫疗法的局限性、肠道微生物群操纵在调节癌症免疫疗法中的生物学功能及其潜在机制,以及膳食真菌补充剂通过调节肠道微生物群促进癌症免疫疗法的益处。